TP53 and B-cell chronic lymphocytic leukemia: SF3B1 mutated CLL samples without concurrent ATM and TP53 aberrations show defective apoptotic responses following treatment with DNA-damaging agents including fludarabine, doxorubicin or IR due to decreased upregulation of several genes including those encoding p21, BAX and PUMA [28].